Verified source report
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
What happened
According to STAT’s source item, STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending, You’re reading the web edition of STAT’s ADA in 30 Seconds, from the American Diabetes Association’s annual conference in New Orleans.
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-06-06T20:54:24+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending via STAT. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet endingSTAT - 2026-06-06T20:54:24+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.